Akash Makkar, MD
Clinical Cardiac Electrophysiology · Phoenix, AZNPI 1770612848
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $211,332 of the $318,130 with a category attached, or 66.4%. Abbott accounts for 75.7% of it on its own, with 40 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,920 payments — averaging $165.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$241K
- Biosense Webster, Inc.$28K
- Boston Scientific$26K
- Medical Device Business Services, Inc.$9K
- Medtronic$4K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$3K
- plus $7K from 35 others
Across 106 payments — averaging $29,426 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$3.1M
- Biosense Webster, Inc.$58K
- Abiomed$133
What the payments were for
- Consulting fees$211,33266%
- Speaking & faculty fees$30,1509%
- Travel & lodging$19,6516%
- Food & beverage$56,87118%
- Education$1260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$158,745
- JETi All In One Non-Sterile Kit$19,250
- Carto 3$15,214
- MitraClip$11,336
- ALLURE$9,400
- GENERAL BRADY$8,700
- AMPLATZER TALISMAN$5,784
- ACCENT$4,800
- GENERAL - THERAPIES$4,376
- Accent Pacemaker$3,601
- QUADRA ASSURA$3,294
- GALLANT$2,706
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$2,250
- LifeVest$2,250
- AMPLATZER$2,216
- AVEIR$1,644
- Thermocool SF$1,449
- Quadra Allure MP RF CRT Pacemkr$1,177
- Micra$1,123
- Confirm Rx$1,085
How this compares
$318,130 in reported general payments places this provider in the 95th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
See all clinical cardiac electrophysiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 456 | $550,527 |
| EntrestoSacubitril/Valsartan | 38 | $53,500 |
| XareltoRivaroxaban | 42 | $51,689 |
| Repatha SureclickEvolocumab | 38 | $27,435 |
| MultaqDronedarone Hcl | 25 | $26,911 |
| FarxigaDapagliflozin Propanediol | 27 | $25,686 |
| VerquvoVericiguat | 29 | $18,839 |
| CorlanorIvabradine Hcl | 22 | $16,417 |
| Midodrine Hcl | 108 | $7,477 |
| Metoprolol Succinate | 513 | $7,449 |
| SotalolSotalol Hcl | 155 | $3,458 |
| Amiodarone Hcl | 203 | $3,165 |
| ClopidogrelClopidogrel Bisulfate | 222 | $3,036 |
| Telmisartan | 137 | $2,963 |
| Mexiletine Hcl | 26 | $2,920 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $550,527456 claims |
| NovartisEntresto | $256 | $53,50038 claims |
| Johnson & JohnsonXarelto | $66 | $51,68942 claims |
| Sanofi-aventis U.S. LLCMultaq | $134 | $26,91125 claims |
| AstraZenecaFarxiga | $86 | $25,68627 claims |
| MerckVerquvo | $442 | $18,83929 claims |
| AmgenCorlanor | $60 | $16,41722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
Other clinical cardiac electrophysiology in Phoenix
- Jonathan WeissPhoenix$290K
- Yoaav KrauthammerPhoenix$238K
- Vijendra SwarupPhoenix$187K
- Paul HaasPhoenix$136K
- Praneeth KatrapatiPhoenix$76K
- Komandoor SrivathsanPhoenix$57K
- Divyashree VarmaPhoenix$49K
- Sushmitha PatibandlaPhoenix$47K
- Mohamed AbdelrahmanPhoenix$45K
- James KnellerPhoenix$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.